| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/02/2001 | WO2001054722A1 Pre-transplant accommodated organs resistant to anti-donor immunity |
| 08/02/2001 | WO2001054721A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
| 08/02/2001 | WO2001054720A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| 08/02/2001 | WO2001054719A2 Vaccine for the prophylactic or therapeutic immunization against hiv |
| 08/02/2001 | WO2001054718A2 Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions |
| 08/02/2001 | WO2001054717A1 Vaccine composition, process and methods |
| 08/02/2001 | WO2001054716A2 Genetically engineered tumor cell vaccines |
| 08/02/2001 | WO2001054712A1 Compositions and methods for the early diagnosis of ovarian cancer |
| 08/02/2001 | WO2001054711A2 Use of neurotoxins for treating diabetes |
| 08/02/2001 | WO2001054707A2 Modification of surface proteins by aminopeptidase inhibitors |
| 08/02/2001 | WO2001054701A1 Vaccination of hiv infected persons following highly active antiretroviral therapy |
| 08/02/2001 | WO2001054672A2 Closure of bacterial ghosts |
| 08/02/2001 | WO2001054652A2 A method of inducing autovaccination against hiv infection using structured treatment interruptions |
| 08/02/2001 | WO2001019997A3 BASB128 polypeptide and polynucleotide from moxarella catarrhalis |
| 08/02/2001 | WO2001018059A3 Congener independent detection of microcystin and nodularin congeners |
| 08/02/2001 | WO2001014548A3 New g-protein coupled receptor and dna sequences thereof |
| 08/02/2001 | WO2001012797A3 Method of separating rotavirus variants and live attenuated rotavirus vaccine |
| 08/02/2001 | WO2001005424A3 Multi-component vaccine to protect against disease caused by haemophilus influenzae and moraxella catarrhalis |
| 08/02/2001 | WO2001004305A3 Human proteins involved in detoxification |
| 08/02/2001 | WO2001004155A3 Feline interleukin-12 as an immune stimulant |
| 08/02/2001 | WO2001000828A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/02/2001 | WO2001000234A3 Methods and compositions for engineering of attenuated vaccines |
| 08/02/2001 | WO2000070036A3 Genes expressed in hippocampus |
| 08/02/2001 | WO2000069898A3 Molecular interactions in allergy cells |
| 08/02/2001 | WO2000065067A3 Prostate-specific polynucleotides, polypeptides and their methods of use |
| 08/02/2001 | WO2000055191A3 Recombinant haemophilus influenzae adhesin proteins |
| 08/02/2001 | WO2000050580A3 Composition, methods and reagents for the synthesis of a soluble form of human phex |
| 08/02/2001 | WO2000047625A3 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 08/02/2001 | US20010011127 Modulating activity of endogenous protein |
| 08/02/2001 | US20010011124 Genetic engineering |
| 08/02/2001 | US20010010926 New immunoregulatory protein lst-1 |
| 08/02/2001 | US20010010924 Inflammation, arthritis, septicemia, brain injury, autoimmune (inflammatory bowel, psoriasis)/bone/acute respiratory diseases, restenosis, AIDS, cancer (lympho-proliferative disorders, atheroscleosis, and Alzheimer's |
| 08/02/2001 | US20010010821 For treatment of gastrointestinal disorders |
| 08/02/2001 | US20010010820 Delaying onset of insulin dependent diabetes mellitus by administering immunologically active monoclonal antibody against glutamic acid decarboxylase coupled to a nonimmunogenic polymer that provides shell around antibody |
| 08/02/2001 | US20010010819 Septicemia |
| 08/02/2001 | US20010010818 Methods and formulations for reducing circulating antibodies |
| 08/02/2001 | US20010010816 Purified FIV-141 virus; vaccines |
| 08/02/2001 | DE19964044A1 Verfahren zur Identifizierung von Substanzen, die Säugetier-Epitope nachahmen A method for identifying substances that mimic epitopes of mammalian |
| 08/02/2001 | DE10011926A1 Genetisch veränderte Fibroblastenzellen Genetically modified fibroblast cells |
| 08/02/2001 | DE10003241A1 Verschließen von Bakterienghosts Closing bacterial ghosts |
| 08/02/2001 | DE10001230A1 Immunisierungsmittel Immunizing agent |
| 08/02/2001 | CA2423122A1 Closure of bacterial ghosts |
| 08/02/2001 | CA2401086A1 Antagonist of th-1 immuneresponse inducing cytokine for the treatment of autoimmune diseases |
| 08/02/2001 | CA2398743A1 Novel mhc class ii restricted t cell epitopes from the cancer antigen, ny eso-1 |
| 08/02/2001 | CA2398611A1 Vaccine for the prophylactic or therapeutic immunization against hiv |
| 08/02/2001 | CA2398503A1 Therapeutic method for reducing angiogenesis |
| 08/02/2001 | CA2398466A1 Ultra high affinity neutralizing antibodies |
| 08/02/2001 | CA2398462A1 Transgenic plant-based vaccines |
| 08/02/2001 | CA2398428A1 Compositions and method for preventing reactogenicity associated with administration of immunogenic live rotavirus compositions |
| 08/02/2001 | CA2398227A1 17 human secreted proteins |
| 08/02/2001 | CA2398139A1 Proteins comprising conserved regions of neisseria meningitidis surface antigen nhha |
| 08/02/2001 | CA2397998A1 Hiv peptides and nucleic acids encoding them for diagnosis and control of hiv infection |
| 08/02/2001 | CA2396884A1 Pharmaceutical composition for immunomodulation and preparation of vaccines comprising an antigen and an immunogenic oligodeoxynucleotide and a polycationic polymer as adjuvants |
| 08/02/2001 | CA2396709A1 Recombinant rhabdoviruses as live-viral vaccines for immunodeficiency viruses |
| 08/02/2001 | CA2396454A1 Recombinant attenuation of prrsv |
| 08/02/2001 | CA2395832A1 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer |
| 08/01/2001 | EP1120654A2 Detection of Alzheimer's disease from cerebrospinal fluid using an immunoassay method |
| 08/01/2001 | EP1120464A2 Stabilizing peptides, polypeptides and antibodies which include them |
| 08/01/2001 | EP1120118A1 Preventives/remedies for infection, anti-endotoxin agents, vaccine adjuvants and growth promoters |
| 08/01/2001 | EP1119629A2 Oxidoreductase molecules |
| 08/01/2001 | EP1119627A2 Ebola virion proteins expressed from venezuelan equine encephalitis (vee) virus replicons |
| 08/01/2001 | EP1119625A1 Glucose-dependent insulinotropic peptide for use as an osteotropic hormone |
| 08/01/2001 | EP1119623A1 Mage-a3 peptides presented by hla class ii molecules |
| 08/01/2001 | EP1119622A2 Bax-mediated apoptosis modulating reagents and methods |
| 08/01/2001 | EP1119620A2 Polynucleotides coding for secreted polypeptides. some having similarity to syncollin or claudin or cytokine. their therapeutic uses |
| 08/01/2001 | EP1119619A2 Nlk1 -interacting proteins |
| 08/01/2001 | EP1119584A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 08/01/2001 | EP1119376A2 Removal of preexisting antibodies to enhance the effectiveness of a therapeutic viral immunogenic agent |
| 08/01/2001 | EP1119375A1 Methods and adjuvants for stimulating mucosal immunity |
| 08/01/2001 | EP1119371A1 Flt4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY |
| 08/01/2001 | EP1119370A1 Reversal of viral-induced systemic shock and respiratory distress by blockade of the lymphotoxin beta pathway |
| 08/01/2001 | EP1119365A1 Composition and method of using tumor cells |
| 08/01/2001 | EP1119349A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 08/01/2001 | EP1119346A2 Rna cancer vaccine and methods for its use |
| 08/01/2001 | EP1119253A1 NOVEL Th2-SPECIFIC MOLECULES AND USES THEREOF |
| 08/01/2001 | EP0975350B1 Use of an extract of alchemilla vulgaris |
| 08/01/2001 | EP0885013B1 Use of multipotent parapox immunity inducers from attenuated, non-immunogenic pox viruses or parapox viruses for the preparation of medicaments |
| 08/01/2001 | EP0806963B1 Carcinoma treatment |
| 08/01/2001 | EP0740703B1 Diagnosis and treatment of infections due to streptococci and enterococci |
| 08/01/2001 | EP0656946B1 Immunoglobulins devoid of light chains |
| 08/01/2001 | EP0538283B2 Synthetic peptides and mixtures thereof for detecting hiv antibodies |
| 08/01/2001 | CN1306576A G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 08/01/2001 | CN1306575A Prodn of attenuated parainfluenza virus vaccines from cloned nucleotide sequences |
| 08/01/2001 | CN1306542A Moraxella catharralis proteins |
| 08/01/2001 | CN1306439A Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 08/01/2001 | CN1306438A Adjuvant compsn. and methods for its use |
| 08/01/2001 | CN1306437A Vaccine |
| 08/01/2001 | CN1306008A Conjugate of Lidamycin with active fragment of monoclonal antibody |
| 08/01/2001 | CN1305847A Conjugate of monoclonal antibody medicine using cyclodextrin as coupling agent |
| 08/01/2001 | CN1069060C Method of using active peptide in strengthening animal's immunity and as vaccine adjuvent |
| 07/31/2001 | US6268491 T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 07/31/2001 | US6268488 Active therapeutic agent attached to blocking moiety that is sensitive to catalytic action of molecules having retro-aldol and retro-michael catalytic activity; targeted antitumor, cytotoxic and antibiotic therapy |
| 07/31/2001 | US6268486 Contacting mixture of polypeptide and impurities with specific monoclonal antibody so that binding occurs, desorbing polypeptide from antibody, and collecting polypeptide; immunoaffinity chromatography |
| 07/31/2001 | US6268484 HIV-vaccines |
| 07/31/2001 | US6268477 Amino acid sequence; detection and treatment of atherosclerosis, rheumatoid arthritis, asthma, aids (acquired immune deficiency syndrome); viricides; antiinflammatory agents; antitumor agents; antiarthritic agents |
| 07/31/2001 | US6268472 Modified HGP-30 peptides, conjugates, compositions and methods of use |
| 07/31/2001 | US6268411 Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| 07/31/2001 | US6268341 These polypeptides are useful for treating diseases wherein antagonism of hupar is therapeutically beneficial. |
| 07/31/2001 | US6268221 Drug screening for compound which binds to receptor by transforming host cell with recombinant expression contruct encoding the receptor, expressing in culture, and analyzing cells to determine binding |
| 07/31/2001 | US6268199 An infectious clone transfected with a recombinant nucleic acid of the porcine reproductive respiratory syndrome virus; vaccines |